Considering people at clinical high risk for psychosis with normodopaminergia: Clinical case of progression to treatment-resistant schizophrenia in three years
Asian J Psychiatr
.
2024 May:95:104006.
doi: 10.1016/j.ajp.2024.104006.
Epub 2024 Mar 11.
Authors
Tae Young Lee
1
,
Nahrie S Kim
2
,
Aram Im
2
Affiliations
1
Department of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea. Electronic address: leetaey@gmail.com.
2
Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea.
PMID:
38513511
DOI:
10.1016/j.ajp.2024.104006
No abstract available
Publication types
Letter
Case Reports
MeSH terms
Adult
Antipsychotic Agents / therapeutic use
Disease Progression*
Female
Humans
Psychotic Disorders / drug therapy
Schizophrenia / drug therapy
Schizophrenia, Treatment-Resistant / drug therapy